Skip to content
Close
SEARCH
Let's Talk
Let's Talk

SOFTWARE
Discover Icon

Discover

Visualize rapid, validated insights through real-world data.
Activate Square

Activate

Streamline data preparation with guardrailed workflows.
Substantiate Square

Substantiate

Transform real-world data into decision-grade evidence.
Generate Square

Generate

Safeguard privacy and ensure utility with AI-driven technology.

SERVICES

PARTNERSHIPS

Aetion has entered into an agreement to be acquired by Datavant, a leading health data platform company.   Learn more → 

AdminSep 22, 2021< 1 min read

Measuring Re-identification Risk for Synthetic and Anonymized Data

2022-02-19-Synthetic-Data-Generation-101-1

Khaled El Emam, SVP & GM, Replica Analytics

Khaled El Emam discusses accurate methods for measuring re-identification risk. This new class of risk estimators helps avoid issues experienced with many of the current risk measurement methods.

 

Following the acquisition of Replica Analytics by Aetion, the generative AI technology previously known as Replica Synthesis is now Aetion® Generate and continues to create privacy-enhancing synthetic data.
Learn More

RELATED ARTICLES

AdminJun 10, 2025< 1 min read

Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study

Recruitment shortfalls are a major reason clinical trials fail, often leading to underpowered studies and inconclusive results. ...
Start Reading
AdminJun 10, 2025< 1 min read

Rescuing Low Accrual Clinical Trials with Generative Models

Patient recruitment shortfalls threaten trial success, leading to underpowered studies, increased patient risk, and wasted ...
Start Reading
Natalie Schibell, MPHJun 9, 20254 min read

The Key Takeaway from the AWS Life Sciences Symposium: Data Alone Is Not Enough—Evidence Matters

More than 1,000 leaders from healthcare and life sciences gathered in New York City on May 20–21, 2025, for the seventh annual ...
Start Reading